CRISPR/ cas9介導(dǎo)的基因敲除揭示了NF-κB/RelA在維持人血管細(xì)胞穩(wěn)態(tài)中的守護(hù)作用 二維碼
發(fā)表時(shí)間:2024-08-26 16:01 2018年7月,1中國(guó)科學(xué)院生物物理研究所,中國(guó)科學(xué)院生物大分子**研究中心,中國(guó)科學(xué)院生物大分子國(guó)家實(shí)驗(yàn)室,2中國(guó)科學(xué)院動(dòng)物研究所干細(xì)胞與生殖生物學(xué)國(guó)家重點(diǎn)實(shí)驗(yàn)室,3中國(guó)科學(xué)院動(dòng)物研究所膜生物學(xué)國(guó)家重點(diǎn)實(shí)驗(yàn)室,4中國(guó)科學(xué)院大學(xué),5首都醫(yī)科大學(xué)宣武醫(yī)院國(guó)家老年疾病臨床研究中心,6中國(guó)科學(xué)院干細(xì)胞與再生研究所,7國(guó)家老年醫(yī)學(xué)中心,北京醫(yī)院,衛(wèi)生部老年醫(yī)學(xué)重點(diǎn)實(shí)驗(yàn)室,8暨南大學(xué)再生醫(yī)學(xué)研究所再生醫(yī)學(xué)教育部重點(diǎn)實(shí)驗(yàn)室,(1National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics,Chinese Academy of Sciences, 2 State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, 3 State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, 4 University of Chinese Academy of Sciences, 5 National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital of Capital Medical University, 6 Institute of Stem cell and Regeneration, Chinese Academy of Sciences, 7 The MOH Key Laboratory of Geriatrics, Beijing Hospital, National Center of Gerontology, 8 Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of ging and Regenerative Medicine, JinanUniversity,) Jing Qu研究團(tuán)隊(duì)在《Inflammation》上發(fā)表論文:“CRISPR/Cas9-mediated gene knockout reveals a guardian role of NF-κB/RelA in maintaining the homeostasis of human vascular cells” “CRISPR/ cas9介導(dǎo)的基因敲除揭示了NF-κB/RelA在維持人血管細(xì)胞穩(wěn)態(tài)中的守護(hù)作用” Abstract Vascular cell functionality is critical to blood vessel homeostasis. Constitutive NF-κB activation in vascular cells results in chronic vascular inflammation, leading to various cardiovascular diseases. However, how NF-κB regulates human blood vessel homeostasis remains largely elusive. Here, using CRISPR/Cas9-mediated gene editing, we generated 摘要 血管細(xì)胞的功能對(duì)血管穩(wěn)態(tài)至關(guān)重要。血管細(xì)胞的構(gòu)造性NF-κB活化導(dǎo)致慢性血管炎癥,導(dǎo)致多種心血管疾病。然而,NF-κB如何調(diào)節(jié)人體血管穩(wěn)態(tài)在很大程度上仍然是一個(gè)謎。在這里,我們利用CRISPR/ cas9介導(dǎo)的基因編輯技術(shù),生成RelA敲除的人胚胎干細(xì)胞(hESCs),并將其分化為各種血管細(xì)胞衍生物,研究NF-κB在基礎(chǔ)和炎癥條件下如何調(diào)節(jié)人血管細(xì)胞。多維表型分析和轉(zhuǎn)錄組學(xué)分析顯示,RelA缺乏在基礎(chǔ)條件下通過(guò)細(xì)胞特異性方式調(diào)節(jié)血管細(xì)胞的炎癥、存活、血管發(fā)生、細(xì)胞分化和細(xì)胞外基質(zhì)組織,并在腫瘤壞死因子α (TNFα)刺激下保護(hù)血管細(xì)胞免受凋亡和調(diào)節(jié)血管炎癥反應(yīng)。最后,對(duì)i-κbα敲除血管細(xì)胞基因表達(dá)模式的進(jìn)一步評(píng)估表明,i - κ b α在很大程度上獨(dú)立于RelA信號(hào)傳導(dǎo)。綜上所述,我們的數(shù)據(jù)揭示了NF-κB/RelA在調(diào)節(jié)人類血管穩(wěn)態(tài)中的保護(hù)作用,并為發(fā)現(xiàn)新的治療靶點(diǎn)繪制了人類血管轉(zhuǎn)錄組圖譜。 該論文中,H9 human ESCs體外培養(yǎng)是使用Ausbian特級(jí)胎牛血清完成的。欲了解或購(gòu)買(mǎi)Ausbian特級(jí)胎牛血清可以聯(lián)系北京締一生物400-166-8600. | |
|